Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Proshares Trust (ZBIO) Operating Margin (2023 - 2025)

Historic Operating Margin for Zenas BioPharma (ZBIO) over the last 3 years, with Q1 2025 value amounting to 373.3%.

  • Zenas BioPharma's Operating Margin changed N/A to 373.3% in Q1 2025 from the same period last year, while for Sep 2025 it was 1337.97%, marking a year-over-year change of. This contributed to the annual value of 3277.76% for FY2024, which is 32034700.0% down from last year.
  • Zenas BioPharma's Operating Margin amounted to 373.3% in Q1 2025.
  • Zenas BioPharma's 5-year Operating Margin high stood at 71.25% for Q3 2023, and its period low was 1112.46% during Q4 2024.
  • In the last 3 years, Zenas BioPharma's Operating Margin had a median value of 373.3% in 2025 and averaged 471.5%.